NanoCarrier Co. Ltd
Nano Holdings, Inc. researches, develops, produces, and sells pharmaceuticals using micellar nanoparticles technology in Japan. The company's pipeline products include RUNX1 (mRNA) for the treatment knee osteoarthritis and reduces pain; and NC-6100 PRDM14 (siRNA), which is in phase I clinical trials for the treatment of breast cancer. Its product pipeline also comprises TUG1 (ASO) for glioblastom… Read more
Market Cap & Net Worth: NanoCarrier Co. Ltd (3NQ)
NanoCarrier Co. Ltd (F:3NQ) has a market capitalization of $65.03 Million (€63.35 Million) as of March 18, 2026. Listed on the F stock exchange, this Germany-based company holds position #20485 globally and #2207 in its home market, demonstrating a -2.76% decrease in market value over the past year.
Market capitalization, also known as net worth in stock markets, is calculated by multiplying NanoCarrier Co. Ltd's stock price €0.88 by its total outstanding shares 71993529 (71.99 Million).
NanoCarrier Co. Ltd Market Cap History: 2015 to 2026
NanoCarrier Co. Ltd's market capitalization history from 2015 to 2026. Data shows change from $566.73 Million to $65.03 Million (-18.83% CAGR).
NanoCarrier Co. Ltd Market Cap to Earnings & Revenue Ratios Timeline
This chart shows how NanoCarrier Co. Ltd's valuation ratios have evolved. The Price to Sales (P/S) ratio compares market cap to revenue, while the Price to Earnings (P/E) ratio compares market cap to net income. Lower values may indicate a more undervalued company relative to its financial performance.
Latest Price to Sales (P/S) Ratio
0.54x
NanoCarrier Co. Ltd's market cap is 0.54 times its annual revenue
1728.56x
Lower than industry averageLatest Price to Earnings (P/E) Ratio
N/A
P/E ratio not applicable due to negative or zero earnings
What These Ratios Tell Investors:
- Price to Sales (P/S) Ratio: Shows how much investors are paying for each dollar of the company's sales. Lower P/S ratios may indicate undervaluation.
- Price to Earnings (P/E) Ratio: Shows how much investors are paying for each dollar of the company's earnings. This is one of the most common valuation metrics.
- Trends in these ratios over time can indicate changing investor sentiment about the company's future growth prospects.
- Industry comparison provides context for whether the company is valued higher or lower than peers.
| Year | Market Cap (USD) | Revenue (USD) | Net Income (USD) | P/S Ratio | P/E Ratio |
|---|---|---|---|---|---|
| 2016 | $511.24 Million | $243.00 Million | -$2.54 Billion | 2.10x | N/A |
| 2017 | $339.86 Million | $218.69 Million | -$2.68 Billion | 1.55x | N/A |
| 2018 | $183.27 Million | $259.10 Million | -$5.42 Billion | 0.71x | N/A |
| 2019 | $162.58 Million | $496.73 Million | -$1.81 Billion | 0.33x | N/A |
| 2020 | $178.84 Million | $552.97 Million | -$2.01 Billion | 0.32x | N/A |
| 2021 | $141.15 Million | $313.26 Million | -$2.84 Billion | 0.45x | N/A |
| 2022 | $87.94 Million | $264.03 Million | -$1.88 Billion | 0.33x | N/A |
| 2023 | $87.20 Million | $202.19 Million | -$1.31 Billion | 0.43x | N/A |
| 2024 | $58.38 Million | $135.51 Million | -$780.00 Million | 0.43x | N/A |
| 2025 | $58.38 Million | $108.52 Million | -$835.38 Million | 0.54x | N/A |
Competitor Companies of 3NQ by Market Capitalization
Companies near NanoCarrier Co. Ltd in the global market cap rankings as of March 18, 2026.
Key companies related to NanoCarrier Co. Ltd by market ranking:
- Vertex Pharmaceuticals Inc (NASDAQ:VRTX): Ranked #162 globally with a market cap of $117.09 Billion USD.
- Regeneron Pharmaceuticals Inc (NASDAQ:REGN): Ranked #281 globally with a market cap of $74.80 Billion USD.
- CSL Limited (PINK:CMXHF): Ranked #344 globally with a market cap of $63.46 Billion USD.
- argenx SE (OTCGREY:ARGNF): Ranked #500 globally with a market cap of $42.99 Billion USD.
| Rank | Company | Symbol | Market Cap | Price |
|---|---|---|---|---|
| #162 | Vertex Pharmaceuticals Inc | NASDAQ:VRTX | $117.09 Billion | $462.49 |
| #281 | Regeneron Pharmaceuticals Inc | NASDAQ:REGN | $74.80 Billion | $759.05 |
| #344 | CSL Limited | PINK:CMXHF | $63.46 Billion | $149.87 |
| #500 | argenx SE | OTCGREY:ARGNF | $42.99 Billion | $697.42 |
NanoCarrier Co. Ltd Historical Marketcap From 2015 to 2026
Between 2015 and today, NanoCarrier Co. Ltd's market cap moved from $566.73 Million to $ 65.03 Million, with a yearly change of -18.83%.
| Year | Market Cap | Change (%) |
|---|---|---|
| 2026 | €65.03 Million | +11.39% |
| 2025 | €58.38 Million | 0.00% |
| 2024 | €58.38 Million | -33.05% |
| 2023 | €87.20 Million | -0.84% |
| 2022 | €87.94 Million | -37.70% |
| 2021 | €141.15 Million | -21.07% |
| 2020 | €178.84 Million | +10.00% |
| 2019 | €162.58 Million | -11.29% |
| 2018 | €183.27 Million | -46.08% |
| 2017 | €339.86 Million | -33.52% |
| 2016 | €511.24 Million | -9.79% |
| 2015 | €566.73 Million | -- |
End of Day Market Cap According to Different Sources
On Mar 18th, 2026 the market cap of NanoCarrier Co. Ltd was reported to be:
| Source | Market Cap |
|---|---|
| Yahoo Finance | $65.03 Million USD |
| MoneyControl | $65.03 Million USD |
| MarketWatch | $65.03 Million USD |
| marketcap.company | $65.03 Million USD |
| Reuters | $65.03 Million USD |
Market cap values may vary slightly between sources due to differences in calculation methods, timing, and data refresh rates.